BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2319289)

  • 1. Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.
    Tonn JC; Schönmayr R; Kraemer HP
    J Neurooncol; 1990 Feb; 8(1):41-5. PubMed ID: 2319289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor spectra of ranimustine against various human tumors].
    Fujimoto S; Tokita H; Nitta K
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2417-22. PubMed ID: 1952961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].
    Oguro M; Yanagawa T; Takenaga K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2550-6. PubMed ID: 6594974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracarotid infusion of ACNU and BCNU as adjuvant therapy of malignant gliomas. Clinical aspects and critical considerations.
    Papavero L; Loew F; Jaksche H
    Acta Neurochir (Wien); 1987; 85(3-4):128-37. PubMed ID: 3035882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative studies on anti-tumor effects of nitrosoureas, ACNU and MCNU, on experimental brain tumors (author's transl)].
    Harada K; Kiya K; Okamoto H; Uozumi T
    Neurol Med Chir (Tokyo); 1981 Oct; 21(10):1017-23. PubMed ID: 6172720
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial of MCNU for malignant brain tumors].
    Harada K; Okamoto H; Fujioka Y; Uozumi T; Kiya K; Kitaoka T; Goishi A; Sasaki U; Shima T; Inagawa T
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxicity of local administration of two nitrosoureas in malignant gliomas.
    Yamashima T; Yamashita J; Shoin K
    Neurosurgery; 1990 May; 26(5):794-9. PubMed ID: 2352597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage between O6-methylguanine-DNA methyltransferase (O6-MT) activity and cellular resistance to antitumour nitrosoureas in cultured rat brain tumour cell strains.
    Mineura K; Fushimi S; Kowada M; Isowa G; Ishizaki K; Ikenaga M
    Acta Neurochir (Wien); 1990; 103(1-2):62-6. PubMed ID: 2360469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro effect of combined use of BH-AC and nitrosourea derivatives against adriamycin-resistant human leukemia cell line].
    Oguro M; Sakai C; Takagi T; Matsuura Y
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2403-8. PubMed ID: 1952959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA lability induced by nimustine and ramustine in rat glioma cells.
    Mineura K; Fushimi S; Itoh Y; Kowada M
    J Neurol Neurosurg Psychiatry; 1988 Nov; 51(11):1391-4. PubMed ID: 3236017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients.
    Wolff JE; Berrak S; Koontz Webb SE; Zhang M
    J Neurooncol; 2008 May; 88(1):57-63. PubMed ID: 18253699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-resistance pattern in brain tumour cells resistant to antitumour chloroethylnitrosoureas.
    Mineura K; Ishiyama Y; Kowada M
    Neurol Res; 1992 Mar; 14(1):45-8. PubMed ID: 1351258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effects of ACNU, BCNU, CDDP, and bleomycin on human glioma cells.
    Iwata K; Yung WK; Fields WS
    Neurol Med Chir (Tokyo); 1988 Oct; 28(10):965-9. PubMed ID: 2462685
    [No Abstract]   [Full Text] [Related]  

  • 14. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
    Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schachenmayr W; Schönmayr R
    J Neurooncol; 1992 May; 13(1):13-24. PubMed ID: 1613536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on three patients with malignant glioma showing tumor reduction during maintenance therapy with MCNU].
    Kiya K; Uozumi T; Kurisu K; Mikami T; Sugiyama K; Monden S; Maeda H; Matsuoka T; Matsuda Y; Harada K
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1083-6. PubMed ID: 8512339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MCNU effectiveness on brain tumor. Part I: Antitumor activity in vitro on human glioma and neuroblastoma cell lines].
    Wakabayashi T; Yoshida J; Inoue I; Kageyama N; Nagata M; Kanzaki M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1098-106. PubMed ID: 6586113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal enhancement of ACNU and potentiation of thermochemotherapy with ACNU by hypertonic glucose in the BT4An rat glioma.
    Schem BC; Dahl O
    J Neurooncol; 1991 Jun; 10(3):247-52. PubMed ID: 1895166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for progressive pilocytic astrocytomas in the chiasmo-hypothalamic regions.
    Nishio S; Morioka T; Takeshita I; Shono T; Inamura T; Fujiwara S; Fukui M
    Clin Neurol Neurosurg; 1995 Nov; 97(4):300-6. PubMed ID: 8599896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary experimental results with the nitrosourea derivative ACNU in the treatment of malignant gliomas.
    Bamberg M; Budach V; Stuschke M; Gerhard L
    Radiother Oncol; 1988 May; 12(1):25-9. PubMed ID: 3165537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro sensitivity of nitrosourea-induced neurogenic tumors to ACNU.
    Kida Y; Cravioto H; Hochwald G; Ransohoff J
    Anticancer Res; 1982; 2(1-2):79-87. PubMed ID: 6956245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.